The efficacy of recombinant Turkey Herpesvirus vector vaccine against Influenza H5 subtype: Benefits from 10 years hindsight and overview of experimental and field data

dc.contributor.author	Fournier, Mathilde
dc.date.accessioned	2022-03-01T09:13:15Z
dc.date.available	2022-03-01T09:13:15Z
dc.date.issued	2021
dc.identifier.uri	http://hdl.handle.net/10832/3105
dc.description.abstract	Incidence of Highly Pathogenic Avian Influenza (HPAI) outbreaks keeps increasing throughout the world and biosecurity measures do not manage to contain it anymore.	en_US
dc.language.iso	en	en_US
dc.title	The efficacy of recombinant Turkey Herpesvirus vector vaccine against Influenza H5 subtype: Benefits from 10 years hindsight and overview of experimental and field data	en_US
dc.type	Thesis	en_US